Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Lupin Manufacturing Solutions, PolyPeptide Group forge long term Peptide alliance

Bayer, Thermo Fisher Scientific join hands to increase patient access to precision cancer medicines

Ruchika Sharma25 March 2024 12:30 PM IST

Berlin: Bayer AG and Thermo Fisher Scientific Inc. have announced a collaboration to develop next-generation sequencing (NGS)-based companion...

Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 crore

Lonza to buy large-scale biologics Vacaville site from Roche for USD 1.2 billion

Ruchika Sharma25 March 2024 10:00 AM IST

Basel: Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has announced it has signed an agreement...

Zydus Lifesciences receives tentative approval from USFDA for Letermovir Tablets

Ruchika Sharma24 March 2024 2:30 PM IST

Letermovir tablets are used to prevent disease caused by a virus called cytomegalovirus in people who have received a bone marrow transplant or kidney...

Novartis concludes acquisition of Tourmaline Bio

Novartis Fabhalta gets positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria

Ruchika Sharma24 March 2024 2:30 PM IST

Basel: Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...

Advent to Sell Zentiva to Private Equity GTCR in USD 4.8 Billion Deal, Closing Expected in 2026

Gilead Sciences completes acquisition of CymaBay Therapeutics for USD 4.3 billion

Ruchika Sharma24 March 2024 11:00 AM IST

As a result of the completion of the merger, CymaBay has become a wholly owned subsidiary of Gilead.

Ropanicant Phase-2b trial for Major Depressive Disorder achieves 100 percent enrollment ahead of schedule: Suven Life Sciences

Bill & Melinda Gates Medical Research Institute begins Phase 3 clinical trial of Tuberculosis vaccine

Ruchika Sharma24 March 2024 10:00 AM IST

Cambridge: The Bill & Melinda Gates Medical Research Institute (Gates MRI) has announced that a Phase 3 clinical trial to assess the efficacy of...

Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market

Novo Nordisk Awiqli recommended for approval for diabetes by European regulatory authorities

Ruchika Sharma23 March 2024 2:12 PM IST

Awiqli is a once-weekly basal insulin analogue designed to cover the basal insulin requirements for a full week with a single subcutaneous injection.

USFDA Approves Bionpharmas Generic HIV Drug Etravirine

USFDA grants full approval for Abbvie Elahere for certain ovarian cancer patients

Ruchika Sharma23 March 2024 1:15 PM IST

North Chicago, Ill.: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has granted full approval for ELAHERE...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

JnJ gets USFDA nod for Opsynvi for chronic treatment of adults with pulmonary arterial hypertension

Ruchika Sharma23 March 2024 12:23 PM IST

Raritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI - a single-tablet combination...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

USFDA successfully concludes inspection at Neuland Labs Bonthapally facility

Ruchika Sharma22 March 2024 4:31 PM IST

Hyderabad: Neuland Laboratories Limited has announced that the United States Food and Drug Administration (US FDA) has successfully...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

Bristol Myers Squibb Abecma approved in European Union for triple-class exposed relapsed and refractory multiple myeloma

Ruchika Sharma22 March 2024 4:02 PM IST

Princeton: Bristol Myers Squibb has announced that the European Commission (EC) has granted approval to Abecma (idecabtagene vicleucel;...

Takeda bags accelerated USFDA nod for Iclusig with chemotherapy in adult patients with newly diagnosed Ph+ ALL

Ruchika Sharma22 March 2024 11:57 AM IST

Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok